Total study population (n=81)
| Baseline | |
|---|---|
| Age (years) | 51±16 |
| Males (n) | 30 |
| WHO II/III/IV (%) | 43/51/6 |
| BNP (pg/mL) median, 25–75th | 204, 67–361 |
| 6-MWD (m) | 354±127 |
| Naive patients (%) | 41 |
| HR (bpm) | 79±15 |
| Systolic BP (mm Hg) | 124±22 |
| mPAP (mm Hg) | 50.6±13.1 |
| CI (L/min/m2) | 2.4±0.6 |
| PVR (dyn/s cm5) | 836±412 |
| RAP (mm Hg) | 8.5±6.2 |
| TAPSE (mm) | 15.3±4.2 |
| RVEDD (mm) | 36.5±7.3 |
| RVEDA (cm2) | 29.5±9.0 |
| RVFAC (%) | 27±12 |
| RV wall thickness (mm) | 6.4±1.6 |
| Moderate/severe tricuspid regurgitation (%) | 59 |
| TAPSE/PASP | 0.21±0.10 |
6-MWD, 6 min walk distance; BNP, brain natriuretic peptide; BP, blood pressure; CI, cardiac index; HR, heart rate; mPAP, mean pulmonary artery pressure; PASP, Doppler estimate of systolic pulmonary artery pressure; PVR, pulmonary vascular resistance; RAP, right atrial pressure; RVEDA, right ventricular end diastolic area; RVEDD, right ventricular end diastolic diameter; RVFAC, right ventricular fractional area change; TAPSE, tricuspid annular plane systolic excursion.